Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212


Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.

Liu JM, Young NS, Walsh CE, Cottler-Fox M, Carter C, Dunbar C, Barrett AJ, Emmons R.

Hum Gene Ther. 1997 Sep 20;8(14):1715-30.


A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.

Walsh CE, Grompe M, Vanin E, Buchwald M, Young NS, Nienhuis AW, Liu JM.

Blood. 1994 Jul 15;84(2):453-9.


Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.

Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS, Liu JM.

J Clin Invest. 1994 Oct;94(4):1440-8.


Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).

Liu JM, Kim S, Read EJ, Futaki M, Dokal I, Carter CS, Leitman SF, Pensiero M, Young NS, Walsh CE.

Hum Gene Ther. 1999 Sep 20;10(14):2337-46.


Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.

Kang EM, Hanazano Y, Frare P, Vanin EF, De Witte M, Metzger M, Liu JM, Tisdale JF.

Mol Ther. 2001 Jun;3(6):911-9.


Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer.

Fu KL, Foe JR, Joenje H, Rao KW, Liu JM, Walsh CE.

Blood. 1997 Nov 1;90(9):3296-303.


Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.

Yamada K, Olsen JC, Patel M, Rao KW, Walsh CE.

Mol Ther. 2001 Apr;3(4):485-90.


Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution.

Haneline LS, Li X, Ciccone SL, Hong P, Yang Y, Broxmeyer HE, Lee SH, Orazi A, Srour EF, Clapp DW.

Blood. 2003 Feb 15;101(4):1299-307. Epub 2002 Oct 10.


In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.

Río P, Segovia JC, Hanenberg H, Casado JA, Martínez J, Göttsche K, Cheng NC, Van de Vrugt HJ, Arwert F, Joenje H, Bueren JA.

Blood. 2002 Sep 15;100(6):2032-9.


Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.

Galimi F, Noll M, Kanazawa Y, Lax T, Chen C, Grompe M, Verma IM.

Blood. 2002 Oct 15;100(8):2732-6.


Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells.

Segal GM, Magenis RE, Brown M, Keeble W, Smith TD, Heinrich MC, Bagby GC Jr.

J Clin Invest. 1994 Aug;94(2):846-52.


Phenotypic correction of Fanconi anemia group C knockout mice.

Gush KA, Fu KL, Grompe M, Walsh CE.

Blood. 2000 Jan 15;95(2):700-4.


The Fanconi anemia polypeptide FACC is localized to the cytoplasm.

Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD.

Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6712-6.


[Progress of research on protein composition and gene therapy of Fanconi anaemia - review].

Li ZY, Zou YF, Deng YB.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Apr;12(2):231-5. Review. Chinese.


Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.

Otsuki T, Wang J, Demuth I, Digweed M, Liu JM.

Int J Hematol. 1998 Apr;67(3):243-8.


Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.

Carreau M, Gan OI, Liu L, Doedens M, McKerlie C, Dick JE, Buchwald M.

Blood. 1998 Apr 15;91(8):2737-44.

Supplemental Content

Support Center